PNC-27

PNC-27 joins a fragment of the p53 protein to a membrane-crossing sequence. In laboratory studies it binds to a protein on the surface of cancer cells and damages their membranes.

It has never been through clinical trials, and regulators have warned against products sold as cancer treatments. It is not a substitute for medical care.

Before you buy

• A lab report for this exact batch (a Certificate of Analysis)
• A batch number on the vial that matches the report
• A sealed vial of freeze-dried powder, stored cold and away from light as the label requires

Informational summary only, not medical advice. Read the safety guide and consult a qualified healthcare professional.